The FDA has cleared Reverse Medical to market its MVP micro vascular plug, which aids in reducing blood flow in patients undergoing peripheral artery embolization. The company also recently obtained regulatory approval for the product in Europe, where the first patients were treated with the device in June.

Related Summaries